Rocket


News + Filings
Transactions





O'Loughlin Steve

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
07/01/2022Actinium Pharmaceuticals, Inc.ATNMGrantStock Option (Right to Buy)256.4k$0.00$0 07/01/2022
09/01/2021Actinium Pharmaceuticals, Inc.ATNMGrantStock Option (Right to Buy)107.5k$0.00$0 09/01/2021
08/12/2020Actinium Pharmaceuticals, Inc.ATNMGrantStock Option (Right to Buy)59.1k$0.00$0 08/12/2020
07/12/2019Actinium Pharmaceuticals, Inc.ATNMGrantOptions to purchase common stock400k$0.23$92.8k 07/12/2019
12/10/2018Actinium Pharmaceuticals, Inc.ATNMPurchaseCommon Stock10k$0.44$4.4k 12/10/2018
07/13/2018Actinium Pharmaceuticals, Inc.ATNMGrantOptions to purchase common stock265k$0.78$207.5k 07/13/2018
06/15/2018Actinium Pharmaceuticals, Inc.ATNMPurchaseCommon Stock12k$0.50$6k 06/15/2018
03/06/2018Actinium Pharmaceuticals, Inc.ATNMOther (acquisition)Common Stock10k$0.50$5k 03/06/2018
03/06/2018Actinium Pharmaceuticals, Inc.ATNMOther (acquisition)Series A Warrants2.5k$0.60$1.5k 03/06/2018
03/06/2018Actinium Pharmaceuticals, Inc.ATNMOther (acquisition)Series B Warrants7.5k$0.70$5.2k 03/06/2018
06/15/2017Actinium Pharmaceuticals, Inc.ATNMPurchaseCommon stock3.5k$1.17$4.1k 06/15/2017

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy